Business Description
Kyowa Kirin Co Ltd
ISIN : JP3256000005
Description
Kyowa Kirin Co Ltd is a drug manufacturing company that focuses on biologic medicines. Its operations emphasize four categories: nephrology, oncology, immunology and allergy, and the central nervous system. The company has two reportable segments, Pharmaceuticals and Biochemicals. The pharmaceuticals business manufactures and sells ethical pharmaceuticals, diagnostic reagents, and other products. The biochemicals business manufactures and sells raw materials for pharmaceutical and industrial use, mainly amino acids, nucleic acids and related compounds, healthcare products, and others.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | No Debt | |||||
| Equity-to-Asset | 0.81 | |||||
| Interest Coverage | 55.51 | |||||
| Piotroski F-Score | 7/9 | |||||
| Altman Z-Score | 5.69 | |||||
| Beneish M-Score | -2.28 | |||||
| WACC vs ROIC | ||||||
Growth Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 11.6 | |||||
| 3-Year EBITDA Growth Rate | 17.5 | |||||
| 3-Year EPS without NRI Growth Rate | 19.9 | |||||
| 3-Year FCF Growth Rate | 168.4 | |||||
| 3-Year Book Growth Rate | 6.2 | |||||
| Future 3-5Y Total Revenue Growth Rate Estimate | 5.06 |
Momentum Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 39.38 | |||||
| 9-Day RSI | 11 | |||||
| 14-Day RSI | 7.36 | |||||
| 6-1 Month Momentum % | 20.97 | |||||
| 12-1 Month Momentum % | 17.55 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 3.52 | |||||
| Quick Ratio | 3.02 | |||||
| Cash Ratio | 2.02 | |||||
| Days Inventory | 211.41 | |||||
| Days Sales Outstanding | 85.73 | |||||
| Days Payable | 282.9 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 2.33 | |||||
| Dividend Payout Ratio | 0.36 | |||||
| 3-Year Dividend Growth Rate | 8.4 | |||||
| Forward Dividend Yield % | 2.34 | |||||
| 5-Year Yield-on-Cost % | 3.57 | |||||
| Shareholder Yield % | 5.14 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 74.3 | |||||
| Operating Margin % | 21.67 | |||||
| Net Margin % | 16.74 | |||||
| FCF Margin % | 9.42 | |||||
| ROE % | 10.06 | |||||
| ROA % | 8.12 | |||||
| ROIC % | 15.34 | |||||
| 3-Year ROIIC % | 38.58 | |||||
| ROC (Joel Greenblatt) % | 63.47 | |||||
| ROCE % | 11.97 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 15.86 | |||||
| Forward PE Ratio | 16.87 | |||||
| PE Ratio without NRI | 15.86 | |||||
| Shiller PE Ratio | 26.58 | |||||
| Price-to-Owner-Earnings | 18.94 | |||||
| PEG Ratio | 1.98 | |||||
| PS Ratio | 2.8 | |||||
| PB Ratio | 1.61 | |||||
| Price-to-Tangible-Book | 2.45 | |||||
| Price-to-Free-Cash-Flow | 30.42 | |||||
| Price-to-Operating-Cash-Flow | 13.88 | |||||
| EV-to-EBIT | 9.59 | |||||
| EV-to-Forward-EBIT | 10.39 | |||||
| EV-to-EBITDA | 7.8 | |||||
| EV-to-Forward-EBITDA | 8.56 | |||||
| EV-to-Revenue | 2.05 | |||||
| EV-to-Forward-Revenue | 2.24 | |||||
| EV-to-FCF | 22.98 | |||||
| Price-to-Projected-FCF | 1.15 | |||||
| Price-to-Median-PS-Value | 0.82 | |||||
| Price-to-Peter-Lynch-Fair-Value | 1.16 | |||||
| Price-to-Graham-Number | 1.25 | |||||
| Price-to-Net-Current-Asset-Value | 4.12 | |||||
| Price-to-Net-Cash | 13.19 | |||||
| Earnings Yield (Greenblatt) % | 10.43 | |||||
| FCF Yield % | 3.56 | |||||
| Forward Rate of Return (Yacktman) % | 15.36 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:KYKOF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Kyowa Kirin Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 3,365.683 | ||
| EPS (TTM) ($) | 1.056 | ||
| Beta | 0.38 | ||
| Volatility % | 35.49 | ||
| 14-Day RSI | 7.36 | ||
| 14-Day ATR ($) | 0.092443 | ||
| 20-Day SMA ($) | 16.96916 | ||
| 12-1 Month Momentum % | 17.55 | ||
| 52-Week Range ($) | 15.78 - 22.214 | ||
| Shares Outstanding (Mil) | 524.72 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 7 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Kyowa Kirin Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Kyowa Kirin Co Ltd Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Kyowa Kirin Co Ltd Frequently Asked Questions
What is Kyowa Kirin Co Ltd(KYKOF)'s stock price today?
The current price of KYKOF is $16.75. The 52 week high of KYKOF is $22.21 and 52 week low is $15.78.
When is next earnings date of Kyowa Kirin Co Ltd(KYKOF)?
The next earnings date of Kyowa Kirin Co Ltd(KYKOF) is .
Does Kyowa Kirin Co Ltd(KYKOF) pay dividends? If so, how much?
The Dividend Yield %  of Kyowa Kirin Co Ltd(KYKOF) is 2.33% (As of Today), Highest Dividend Payout Ratio of Kyowa Kirin Co Ltd(KYKOF) was 0.73. The lowest was 0.35. And the median was 0.48. The  Forward Dividend Yield % of Kyowa Kirin Co Ltd(KYKOF) is 2.34%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers